We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MorphoSys Initiates Phase 2 Study of MOR208 in NHL

News   May 13, 2013

 
MorphoSys Initiates Phase 2 Study of MOR208 in NHL
 
 
 

RELATED ARTICLES

Molecular Clues to the Link Between ALS and Type 2 Diabetes

News

New research has exposed a link between immunoglobulins in the blood and the common occurrence of Type 2 diabetes in patients with ALS.

READ MORE

A Prescription of Short-term Exercise Could Help Reduce the Side-effects of Prostate Hormone Therapy

News

A prescription of short-term exercise for patients with advanced prostate cancer could help to reduce the side-effects of hormone therapy, according to new research from the University of East Anglia.

READ MORE

"Undetectable Equals Untransmittable" Now the Accepted HIV Message

News

People living with HIV who achieve and maintain an undetectable viral load by taking antiretroviral therapy as prescribed do not sexually transmit HIV to others. The U.S. Centers for Disease Control and Prevention estimates this strategy is 100% effective against the sexual transmission of HIV.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE